The latest news in cancer research, health and policy by Cancer Research UK.
We cover developments in cancer treatments, research into cancer risk and diagnosis as well as the latest cancer science stories. You'll also find analysis and comment on health and cancer policy.
People over 65 are around seven times more likely to develop malignant melanoma compared to 40 years ago.
A long-term follow up of people on a clinical trial has confirmed the benefit of immunotherapy for some patients with advanced melanoma.
Manchester researchers are developing a new generation of targeted melanoma drugs that could bypass treatment resistance seen with current therapies.
Can you help a research team grow 3D lung tissue in a lab to help study cancer? Can we track how moving skin cancer cells give the immune system the slip? Or is there a...
From flashing green men to high-pitched beeping, when we cross the road there are plenty of signals to help us.
But if these cues fail, it can cause us to hesitate...
Cancer Research UK scientists have discovered that melanoma cells are drawn to follow the ‘trail’ of a naturally-occurring molecule in the body.
Immune cells may be responsible for drug resistance in melanoma patients, according to research published in Cancer Discovery.